May 8, 2017
Japanese health app maker Welby announced three new apps last month developed in partnership with pharma companies. Welby will add to its lineup three apps available only in Japan: an app for irritable bowel disease patients with Johnson & Johnson subsidiary Janssen; an app for pulmonary arterial hypertension (PAH) patients with Japanese pharma company Nippon Shinyaku, and an app for...
March 6, 2017
Japanese digital health company Welby has collaborated with Janssen, a pharmaceutical division of Johnson & Johnson, to develop a mobile app for people with attention deficit hyperactivity disorder, or ADHD. The app will be available on iOS and Android throughout Japan.
Aozora, the task management app, was created by Welby and will be distributed by Janssen to people with ADHD who are...
February 9, 2016
It’s been almost a year since IBM launched its newest health-focused business unit, called Watson Health and a new cloud offering called the Watson Health Cloud.
Before IBM formalized Watson Health, the company's well-known super computer brand had already been involved in healthcare for some time, partnering with Memorial Sloan-Kettering Cancer Center in New York City and Welltok. And at the...
November 12, 2015
LifeScan, a Johnson and Johnson company, just announced that its companion app, Reveal, for people with diabetes who use the OneTouch Verio Sync Meter, now enables data sharing with third party apps through Apple's HealthKit. The new functionality means Verio and Reveal users can now easily share their glucose numbers with any other health app that connects through Apple's HealthKit exchange....
August 27, 2015
Johnson and Johnson Innovation (JJI) is teaming up with hardware manufacturing company PCH to create Hardware for Health, an accelerator of sorts for companies with a consumer health oriented hardware prototype.
"If you look at what’s happening in hardware, there’s really a renaissance going on," Stacy Feld, Senior Director of Consumer Scientific Innovation at JJI, told MobiHealthNews. "There...
June 15, 2015
McNeil Consumer Healthcare, the Johnson & Johnson subsidiary that makes over the counter medications like Tylenol and Zyrtec, has released a new mobile app, called Healthyday, that uses crowdsourced data to inform users about location-based allergy, cold, and flu trends. Update: The app is the first to make use of an API from Sickweather, a company that has offered its own version of a health...
May 4, 2015
Johnson & Johnson company LifeScan is launching a clinical trial to determine whether its OneTouch Verio blood glucose meter (or a not-yet-launched version of it) creates a greater reduction in A1C levels when used in conjunction with its companion app.
According to a post on ClinicalTrials.gov, the company is recruiting 148 patients for a randomized control trial that will compare patients...
April 14, 2015
IBM Watson has taken a giant step deeper into the healthcare industry with the formation of a new business unit called Watson Health and a new cloud offering called the Watson Health Cloud. The move also includes some big name partners -- Apple, Johnson and Johnson, and Medtronic -- and two acquisitions: Cleveland-based Explorys and Dallas-based Phytel.
Watson has been involved in healthcare...
September 23, 2014
Janssen Healthcare Innovation, a Johnson and Johnson company, is introducing a provider-facing component to its Care4Today mobile health manager application, the company announced from the stage at Health 2.0 in Santa Clara, California today.
"It’s called the patient dashboard, and it allows provider to manage patient adherence in real time," Janssen marketing director Fran Devlin told...
January 21, 2014
A new report from IMS Health on the use of social media by pharmaceutical companies finds that among the top 50 pharmaceutical companies, half don't engage with consumers and patients through social media. But of those that do, IMS found that Johnson & Johnson emerged as a clear leader. It scored a 70 on IMS's Social Media Engagement Index. The next highest score, from GlaxoSmithkline, was...